These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6339776)

  • 1. Induction of delayed hypersensitivity reactions in cancer patients by cholesterol-hemisuccinate-treated autologous tumor cells.
    Skornick Y; Dresdale AR; Sindelar WF
    J Natl Cancer Inst; 1983 Mar; 70(3):465-7. PubMed ID: 6339776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antigenicity of autologous leukemia cells enriched with cholesterylhemisuccinate.
    Muller CP; Treiber D; Steinke B; Waller HD
    Anticancer Res; 1991; 11(2):925-30. PubMed ID: 2064351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens.
    Skornick Y; Kurman CC; Sindelar WF
    Cancer Res; 1984 Mar; 44(3):946-8. PubMed ID: 6692417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stimulation of antigenicity of renal adenocarcinoma cells].
    Ludes B; Staedel C; Jacqmin D; Cremel G; Hubert P; Saussine C; Beck JP; Bollack C
    J Urol (Paris); 1990; 96(6):295-8. PubMed ID: 2280081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin tests with autologous cholesteryl hemisuccinate treated tumour cells in cancer patients.
    Munzarová M; Zemanová D; Kovarik J; Rejthar A; Pacovsky Z
    Cancer Immunol Immunother; 1985; 20(2):179-81. PubMed ID: 3849981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
    Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
    Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of membrane function by lipids; implications for tumor development.
    Shinitzky M; Skornick Y; Gorelik E; Sindelar W
    Prog Clin Biol Res; 1983; 132B():425-33. PubMed ID: 6634764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin tests with autologous cholesteryl hemisuccinate-treated tumor cells, DNCB and PPD and their relationship to prognosis in malignant melanoma patients.
    Munzarová M; Mechl Z; Kovarík J; Kolcová V
    Neoplasma; 1988; 35(2):229-34. PubMed ID: 3374711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunotherapy of human solid tumor with autologous cells treated with cholesteryl hemisuccinate. A Phase I study.
    Skornick YG; Rong GH; Sindelar WF; Richert L; Klausner JM; Rozin RR; Shinitzky M
    Cancer; 1986 Aug; 58(3):650-4. PubMed ID: 3524790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.
    Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Lim M; Weber CE; Baccala AA; Goemann MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF; Nelson WG
    Cancer Res; 1999 Oct; 59(20):5160-8. PubMed ID: 10537292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
    Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
    Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M-Vax: an autologous, hapten-modified vaccine for human cancer.
    Berd D
    Expert Rev Vaccines; 2004 Oct; 3(5):521-7. PubMed ID: 15485331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study.
    Galligioni E; Quaia M; Merlo A; Carbone A; Spada A; Favaro D; Santarosa M; Sacco C; Talamini R
    Cancer; 1996 Jun; 77(12):2560-6. PubMed ID: 8640706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R; Hodi FS; Haluska F; Jung K; Gillessen S; Singer S; Tanabe K; Duda R; Mentzer S; Jaklitsch M; Bueno R; Clift S; Hardy S; Neuberg D; Mulligan R; Webb I; Mihm M; Dranoff G
    J Clin Oncol; 2003 Sep; 21(17):3343-50. PubMed ID: 12947071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-DR antigens on tumour cells does not contribute to skin reactivity to autologous cholesteryl hemisuccinate (CHS)-treated tumour cells in patients with metastatic melanoma.
    Munzarová M; Zemanová D; Kovarík J; Pacovský Z; Rejthar A; Bártek J
    Cancer Immunol Immunother; 1987; 24(3):272-4. PubMed ID: 3594489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
    Kokoschka EM; Micksche M
    Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.